Bumper Offer - Urjas oil Just @ Rs. 1 X
Melmet-500 Tablets (15) is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Diabetes.
The correct dosage of Melmet-500 Tablets (15) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Melmet-500 Tablets (15) include Stomach Upset, Difficulty urinating. Besides the aforementioned side effects, there are other adverse effects of Melmet-500 Tablets (15) as well, which are listed below. Usually, these side effects of Melmet-500 Tablets (15) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Melmet-500 Tablets (15) has a Mild effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Melmet-500 Tablets (15) related warnings talks about Melmet-500 Tablets (15)'s effects on the liver, heart and kidney.
Melmet-500 Tablets (15) is contraindicated in people with pre-existing medical conditions like Congestive Heart Failure (CHF), Anemia, Shock as it can result in adverse effects. The section on Melmet-500 Tablets (15) contraindications lists all such conditions.
Besides this, Melmet-500 Tablets (15) may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Melmet-500 Tablets (15) is safe while driving, and is is addictive in nature.
Melmet-500 Tablets (15) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Melmet-500 Tablets (15) is used -
Severe
Moderate
Mild
Common
Is the use of Melmet-500 Tablets (15) safe for pregnant women?
Pregnant women may get mild side effects from Melmet.
Is the use of Melmet-500 Tablets (15) safe during breastfeeding?
Breastfeeding women may feel side effects of Melmet. If you see any side effects, stop taking Melmet immediately and talk to your doctor. Take Melmet again, only after your doctor's advice.
What is the effect of Melmet-500 Tablets (15) on the Kidneys?
Melmet is completely safe for kidneys.
What is the effect of Melmet-500 Tablets (15) on the Liver?
Melmet is completely safe for the liver.
What is the effect of Melmet-500 Tablets (15) on the Heart?
You can take Melmet without any fear of damage to the heart.
Melmet-500 Tablets (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Melmet-500 Tablets (15) unless your doctor advises you to do so -
Is this Melmet-500 Tablets (15) habit forming or addictive?
Melmet-500 Tablets (15) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Melmet-500 Tablets (15) does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Melmet-500 Tablets (15) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Melmet-500 Tablets (15) is unable to treat or cure mental disorders.
Interaction between Food and Melmet-500 Tablets (15)
Information is not available on the interaction of any foods with Melmet-500 Tablets (15), due to a lack of research on this.
Interaction between Alcohol and Melmet-500 Tablets (15)
Consumption of alcohol and Melmet-500 Tablets (15) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276